Elevance Health Inc (ELV)

Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell

$400.00

Buy

$417.38

arrow-down$-12.27 (-2.92%)

Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and Specialty Business, Government Business and Other.
Prices updated at 02 May 2025, 00:26 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.63%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Healthcare Plans
Chairman
Ms. Elizabeth E. Tallett
CEO
Ms. Gail Koziara Boudreaux
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
104,200
Head office
220 Virginia Avenue
Indianapolis
United States
46204
mobile
+1 833 401-1577
letter
investor.relations@elevancehealth.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Deanna D. Strable-Soethout
Independent Director
0.13m--0.35m-
Ms. Elizabeth E. Tallett
Chairman of the Board
0.39m--0.61m-
Ms. Gail Koziara Boudreaux
President, Chief Executive Officer and Director
1.60m--20.47m-
Mr. Lewis Hay, III
Independent Director
0.13m--0.35m-
Mr. Ryan M. Schneider
Independent Director
0.16m--0.38m-
Mr. R. Kerry Clark
Independent Director
0.16m--0.38m-
Mr. Ramiro G. Peru
Independent Director
0.16m--0.39m-
Mr. Robert L. Dixon, Jr
Independent Director
0.13m--0.35m-
Dr. Bahija Jallal, PhD
Independent Director
0.16m--0.39m-
Ms. Susan Dodson DeVore
Independent Director
0.13m--0.35m-
Mr. Antonio Fabio Neri
Independent Director
0.13m--0.35m-
Mr. Peter D. Haytaian
Executive Vice President; President of Carelon and CarelonRx
0.95m--6.35m-
Mr. Mark B. Kaye
Executive Vice President and Chief Financial Officer
0.90m--6.87m-
Mr. Ronald W. Penczek
Chief Accounting Officer and Controller
-----
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital and Information Officer
-----
Ms. Felicia F Norwood
Executive Vice President and President, Government Health Benefits
0.95m--6.29m-
Mr. Charles Morgan Kendrick, Jr
Executive Vice President and President, Commercial and Specialty Health Benefits
0.85m--5.79m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc21,485,5740.138061383800.64823531 Mar 20259.52
BlackRock Inc20,442,1860.15259-591440-2.81187831 Mar 20259.06
State Street Corp10,682,2930.15547-5705-0.05337831 Mar 20254.73
T. Rowe Price Associates, Inc.10,618,0620.451554641374.57101131 Mar 20254.71
T Rowe Price Associates, Inc10,171,136--1758726-14.74221631 Mar 20254.39

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
01 Nov 2024-Mr. Peter D. Haytaian414.01682,70217,238--
01 Nov 2024-Mr. Peter D. Haytaian--21,037--
01 Nov 2024-Mr. Charles Morgan Kendrick, Jr--9,287--
01 Nov 2024-Mr. Charles Morgan Kendrick, Jr414.01350,2527,577--
18 Oct 2024-Mr. Charles Morgan Kendrick, Jr432.143,205,1828,423--
02 Oct 2024-Mr. Mark B. Kaye505.161,423,54120,213--
05 Aug 2024-Mr. Ramiro G. Peru531.52400,2358,744--
22 Jul 2024-Ms. Gail Koziara Boudreaux502.231,130,018129,959--
22 Jul 2024-Ms. Gail Koziara Boudreaux498.50548,350159,609--
22 Jul 2024-Ms. Gail Koziara Boudreaux500.3610,396,980138,830--
22 Jul 2024-Ms. Gail Koziara Boudreaux504.271,134,608126,709--
22 Jul 2024-Ms. Gail Koziara Boudreaux501.403,319,769132,209--
22 Jul 2024-Ms. Gail Koziara Boudreaux503.67503,670128,959--
19 Jul 2024-Mr. Robert L. Dixon, Jr506.76154,5629,721--
15 May 2024-Ms. Deanna Strable-Soethout--1,045--
15 May 2024-Ms. Elizabeth E. Tallett--10,291--
15 May 2024-Mr. Lewis Hay, III--10,906--
15 May 2024-Mr. Ryan M. Schneider--5,999--
15 May 2024-Mr. R. Kerry Clark--9,039--
15 May 2024-Mr. Ramiro G. Peru--9,497--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.